Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,903 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL; American Society of Clinical Oncology. Hershman DL, et al. Among authors: smith ml, smith t. J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. J Clin Oncol. 2014. PMID: 24733808 Review.
Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.
Bennett CL, Weeks JA, Somerfield MR, Feinglass J, Smith TJ. Bennett CL, et al. Among authors: smith tj. J Clin Oncol. 1999 Nov;17(11):3676-81. doi: 10.1200/JCO.1999.17.11.3676. J Clin Oncol. 1999. PMID: 10550166
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel.
Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL 3rd, Winn RJ, Wozniak AJ, Somerfield MR; American Society of Clinical Oncology. Ozer H, et al. Among authors: smith tj. J Clin Oncol. 2000 Oct 15;18(20):3558-85. doi: 10.1200/JCO.2000.18.20.3558. J Clin Oncol. 2000. PMID: 11032599 No abstract available.
Doc, shouldn't we be getting some tests?
Loprinzi CL, Hayes D, Smith T. Loprinzi CL, et al. Among authors: smith t. J Clin Oncol. 2003 May 1;21(9 Suppl):108s-111s. doi: 10.1200/JCO.2003.01.190. J Clin Oncol. 2003. PMID: 12743213 No abstract available.
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, Olak J, Stover D, Strawn JR, Turrisi AT, Somerfield MR; American Society of Clinical Oncology. Pfister DG, et al. Among authors: smith tj. J Clin Oncol. 2004 Jan 15;22(2):330-53. doi: 10.1200/JCO.2004.09.053. Epub 2003 Dec 22. J Clin Oncol. 2004. PMID: 14691125 Review. No abstract available.
12,903 results
You have reached the last available page of results. Please see the User Guide for more information.